Abstract
Abstract
Background
Splitting or crushing medications are used for dosage administration when a certain dose is not easily accessible. Understanding the splitting or crushing of medications is essential to guarantee safe medication administration since inappropriate handling might impact therapeutic efficacy, safety and patient outcomes.
Objectives
This study intends to examine the practices, attitudes and knowledge of the Jordanian population regarding the splitting/crushing of medications.
Study design and setting
This is a cross-sectional survey study conducted in Jordan between November 2022 and March 2023. The questionnaire tool was adapted from previous literature, and binary logistic regression analysis was used, to identify the predictors of participants’ knowledge concerning medication splitting/crushing.
Participants
A total of 1259 participants from the general public were involved, without restrictions on gender or age.
Results
Around 22.2% of participants confirmed that tablet splitting/crushing is a useful way to reduce medication costs. 67.0% reported that they are not sure whether tablets are suitable for splitting/crushing/crushing. 75.8% reported that they refer to package leaflet information to check whether tablets are suitable for splitting/crushing. 84.8% correctly believed that scored tablets can be split, while unscored tablets cannot. 72.0% identified correctly that not all types of tablets and capsules can be split/crushed or dissolved. The mean knowledge score of study participants was 2.7 (SD: 1.5) out of 6, which is equal to 45% of the maximum attainable score and reflects a weak level of knowledge about tablet crushing. Those who hold a bachelor’s degree and have an income level of JD500–JD1000 (which is equal to US$715–US$1428) were more likely to have knowledge about tablet crushing. Around 39.2% of the participants reported that they had split or crushed tablets to reach their desired dose, of which the vast majority (82.9%) were using scored tablets.
Conclusion
Understanding of tablet-splitting and crushing techniques ought to be enhanced while encouraging prescribing practices that stress safety and well-informed decision-making. Patients should actively seek reliable sources of information, have an awareness of which tablets can be safely divided and actively engage with healthcare experts to receive appropriate guidance.
Keywords: Awareness; Cross-Sectional Studies; Education, Medical; ORAL MEDICINE; Medication Reconciliation; Medication Review
STRENGTHS AND LIMITATIONS OF THIS STUDY.
The use of a survey study design allows for the examination of practices, attitudes and knowledge among a broader and more geographically diverse segment of the Jordanian population.
The use of an online survey study might have missed some of the study’s target population.
The cross-sectional study design is vulnerable to recall bias and response bias.
Introduction
Crushing or splitting oral solid dose forms (OSDFs) is one of the important contemporary debates from the medical perspective.1,4 OSDFs can be split in order to provide several, smaller doses for various purposes or to offer a lower amount of the active component in a single unit. Crushing solid dosage forms is commonly achieved using appropriate pharmaceutical equipment, such as a mortar and pestle, to smash pills into powder.5 Typically, patients may divide pills for a variety of reasons, including giving the patient the correct dose when the product is not accessible at the necessary strength.6 This method is beneficial for both elderly people and children who have low drug tolerance due to the presence of comorbidities in the elderly7 8 and relatively lower hepatic detoxification of the drug in children.9 10 Therefore, these patients’ groups need to begin therapy with the smallest amount possible and then gradually increase the amount administered of the drug until reaching the ideal dose. This is an ideal approach to improve the tolerability of the medication and decrease the chance of adverse reactions to certain drugs.11
Other advantages of solid dosage forms splitting/crushing include lowering the cost of drugs, making oral administration a convenient and affordable route,12,14 as well as achieving greater flexibility in medication dosage.15 16 Moreover, the large dimensions of the capsules, the unpleasant taste or the number of tablets to be administered make crushing tablets a suitable way of administering medications to patients with swallowing issues such as geriatrics and patients with cardiovascular events, for example, stroke or neurological disorders.17 Grinding pills and subsequently mixing them into food is also thought to be a practical method of administration for people with loss of memory or confusion or patients who refuse to take medications.18 However, it is critical to be aware of the potential consequences of dosage form manipulation.
Drug pharmacological and pharmacokinetic effects can be altered as a result of changing dosage form design through solid dosage form crushing or splitting. Moreover, OSDFs may be broken up or crushed, but this might cause certain issues. For instance, certain corticosteroids may expose pharmacists to dangers through the powder dusting effect.19 This includes breaking or crushing teratogenic or cancer-causing substances like methotrexate. It is well known that the powder of this category of drugs contributes to cross-contamination and poses a substantial risk to workers. Therefore, powder dust is one of the main elements that must be addressed during the production of OSDFs.20 Accordingly, crushing or splitting OSDFs might have harmful consequences.21 Crushing OSDFs also potentially affects drug bioavailability. For potent medications like digoxin and carbamazepine with narrow therapeutic windows, these alterations to the dosage form can be very detrimental. Using small amounts of drugs can produce an effect greater than expected due to the tablet crushing which can spike plasma concentration above the toxic level.22 23
Overall, previous research studies on this specific issue are very limited, particularly in low-income and middle-income countries (LMICs),24,27 and no single study date has been conducted in Jordan which is an LMIC. Therefore, this study intended to examine the practices, attitudes and knowledge of the Jordanian population regarding the splitting and/or crushing of OSDFs. Such a study can help healthcare professionals make medical decisions about whether to crush or split OSDFs and how to do so effectively without affecting patient health and treatment outcomes of the prescribed medications or therapeutic regimen.
Methods
Study design
This is an online cross-sectional survey study that was conducted in Jordan between November 2022 and March 2023.
Sampling technique
This study employed the convenience sampling technique to recruit the study participants. The questionnaire link was circulated through social media platforms (Facebook and WhatsApp) inviting participants who meet the inclusion criteria to participate in the study. The study objectives and inclusion criteria were highlighted in the cover letter along with the survey link.
Study population
The general public formed the study population for this study. The inclusion criteria for this study were individuals aged 18 years and older currently living in Jordan. There were no restrictions on gender, education level, income level or disease history for study participants.
Questionnaire tool
The questionnaire tool used in this study was adapted (modified from an existing survey) based on a previously developed questionnaire tool by Zaid et al.43 The questionnaire tool comprised three sections (online supplemental material). The first section explored the demographic characteristics of the study participants (age, gender, marital status, education level, employment status, monthly income level and history of chronic diseases). The second section examined participants’ attitudes towards medication splitting and crushing and comprised seven questions in yes/no format. The third section examined participants’ knowledge of medication splitting and crushing and comprised six multiple-choice questions. Additionally, tablet-crushing practices were examined using three further multiple-choice questions. For each correct answer, participants were given a score of 1. The maximum attainable score for the knowledge section was 6, the higher the score, the more knowledgeable the participant is about medication splitting and crushing.
Questionnaire reliability and validity
The questionnaire instrument underwent a process of review and validation by pharmacists expert in the fields of pharmaceutics and clinical pharmacy. These experts assessed the instrument’s lucidity and intelligibility, as well as its face validity and the difficulty of comprehending the questions. Furthermore, prior to implementing the survey on a broader scale, a pilot study was undertaken involving a limited sample size of 20 participants to evaluate its clarity and readability. The outcomes of this study validated the questionnaire’s straightforward nature. The purpose of this assessment was to ascertain the questions’ clarity, comprehensibility and suitability, in addition to verifying the content’s propriety and detecting any potential misunderstandings. A content validity assessment was conducted on the questionnaire items in order to ensure that they sufficiently addressed the pertinent subject matter of the study. The task was completed through the participation of experts in a discourse verifying that the inquiries sufficiently covered the pertinent subject matter. The purpose of conducting an assessment of face validity was to determine whether or not the queries effectively captured the intended constructs. In order to ensure the queries’ pertinence and suitability, expert analysis was solicited.
Statistical analysis
The SPSS, V.29 was used to analyse the data for this study. Continuous variables were presented as a mean and (SD) as the data were normally distributed. Categorical variables were presented as frequencies and percentages. Binary logistic regression analysis was used to identify the predictors of participants’ knowledge concerning medication splitting and crushing. The normality of the knowledge score was checked using the histogram and skewness and kurtosis measures. These confirmed the data were normally distributed. The mean knowledge score of the study participants was used to define the dummy variable for the binary logistic regression analysis. The OR with 95% CI was used to present the findings of the regression analysis. The significance level was assigned as a p<0.05.
Patient and public involvement
None.
Sample size
The required sample size for our study population was 385 participants, based on a CI of 95%, an SD of 0.5 and a margin of error of 5%.
Results
Table 1 presents participants’ demographic characteristics. A total of 1259 participants were involved in this study. More than half of the participants were females (63.1%). Around 41.0% of the participants were aged 18–23 years. Single participants comprised 56.6% of the study sample. The majority of participants (79.5%) reported holding a bachelor’s degree. Almost 44.3% of the participants were employed. Almost 79.0% of the participants reported that their monthly income is below JD1000 (less than US$1428). Around 13.3% of participants reported that they have a history of chronic diseases.
Table 1. Participants’ demographic characteristics.
| Variable | Frequency | Percentage |
| Gender | ||
| Female | 794 | 63.1 |
| Age group | ||
| 18–23 years | 519 | 41.2 |
| 34–30 years | 257 | 20.4 |
| 31–35 years | 156 | 12.4 |
| 36–40 years | 127 | 10.1 |
| 41–45 years | 95 | 7.5 |
| 46–50 years | 63 | 5.0 |
| 51 years and over | 42 | 3.3 |
| Marital status | ||
| Single | 713 | 56.6 |
| Married | 514 | 40.8 |
| Divorced | 18 | 1.4 |
| Widowed | 13 | 1.1 |
| Education level | ||
| Secondary school or lower | 111 | 8.8 |
| Bachelor degree | 1001 | 79.5 |
| Higher education | 147 | 11.7 |
| Employment status | ||
| Retired | 20 | 1.6 |
| Unemployed | 202 | 16.0 |
| Employed | 558 | 44.3 |
| University students | 479 | 38.0 |
| Monthly income level | ||
| Less than JD500 | 519 | 41.2 |
| JD500–JD1000 | 480 | 38.1 |
| JD1001–JD1500 | 146 | 11.6 |
| JD1500 and above | 114 | 9.1 |
| Chronic diseases history | ||
| Yes | 168 | 13.3 |
One Jordanian DinarJD1 is equal to US$1.43$.
Attitude towards tablet crushing
We used seven questions to explore participants’ attitudes towards tablet crushing. Around 22.2% of participants confirmed that tablet splitting/crushing is a useful way to reduce medication costs and 33.5% confirmed that physicians should recommend splitting/crushing tablets as often as possible to reduce medication costs. The majority of participants (84.1%) answered that sometimes it is difficult to break tablets due to their size or hardness. More than half of the participants (67.0%) reported that sometimes they are not sure whether tablets are indeed suitable for splitting or crushing. The majority of participants (75.8%) reported that they would check package leaflet information to see whether tablets are suitable for splitting or crushing. A similar percentage (76.8%) reported that they have never asked healthcare professionals how to split tablets. The vast majority of participants (90.0%) reported that modifying the dosage form is part of the doctor’s role or responsibility. Further detail on participants’ responses regarding their attitude towards tablet-crushing items is available in table 2.
Table 2. Participants’ response to attitude towards tablet-crushing items.
| Number | Variable | Percentage | |
| Yes | No | ||
| 1 | Tablet splitting is a useful way to reduce medication costs | 22.2 | 77.8 |
| 2 | To reduce medication costs physician should recommend split tablets as often as possible | 33.5 | 66.5 |
| 3 | Sometimes it is difficult to break tablets (eg, because they are very small or hard) | 84.1 | 15.9 |
| 4 | Sometimes I am not sure whether tablets are indeed suitable for splitting or crushing | 67.0 | 33.0 |
| 5 | If tablets are not suitable for splitting or crushing, I would check this information in the package leaflet | 75.8 | 24.2 |
| 6 | I have never asked expert (pharmacist, nurse, doctor) on how to split tablets best | 76.8 | 23.2 |
| 7 | I think that modifying the dosage form is part of the doctor’s role or responsibility | 90.0 | 10.0 |
Knowledge of tablet crushing
The vast majority of the participants (84.8%) correctly responded that scored tablets can be split, while unscored tablets cannot. Only 11.2% of the participants did not identify correctly which tablets cannot be split or crushed. Only 24.0% of participants were able to identify correctly that scored tablets are divided into equal parts. The majority of participants (72.0%) identified correctly that not all types of tablets and capsules can be split, crushed or dissolved. More than half of participants (67.1%) identified correctly that crushing an enteric-coated nonsteroidal anti-inflammatory drugs (NSAID) tablet might increase its side effects. Around 61.0% of participants identified correctly that crushing a sustained-release tablet reduces its therapeutic efficacy (table 3).
Table 3. Participants’ responses for knowledge of tablet-crushing items.
| Number | Variable | Percentage |
| Yes | ||
| 1 | Do you know that scored tablets can be split, while unscored tablets cannot? | 84.8 |
| 2 | Which one of the following tablets cannot be split or crushed? | |
| 1 | 81.9 | |
| 2 | 0.7 | |
| 3 | 0.8 | |
| 4 | 1.5 | |
| 5 | 3.8 | |
| All of them could be split or crushed | 11.2 | |
| 3 | Sometimes even scored tablets cannot be divided into equal parts? | 76.1 |
| 4 | If required, all tablets and capsules may be split or crushed or dissolved? | 28.0 |
| 5 | Do you know that crushing an enteric coated NSAID’s tablet such as ibuprofen (Advil) might increase the side effects of NSAIDs such as gastric discomfort/heart burn? | 67.1 |
| 6 | Do you know that crushing a sustained-release tablet such as Pentasa (mesalazine) reduces its therapeutic efficacy? | 60.8 |
Predictors of participants’ knowledge
The mean knowledge score of the study participants was 2.7 (SD: 1.5) out of 6, which is equal to 45% of the maximum attainable score, and reflects a weak level of knowledge of tablet crushing. Binary logistic regression analysis identified that those who hold a bachelor degree and have an income level of JD500–JD1000 per month were more likely to be knowledgeable of tablet crushing (see table 4).
Table 4. Binary logistic regression analysis.
| Variable | OR | 95% CI |
| Gender | ||
| Females (reference group) | 1.00 | |
| Males | 0.81 | 0.64 to 1.02 |
| Age group | ||
| 18–23 years (reference group) | 1.00 | |
| 34–30 years | 1.12 | 0.85 to 1.49 |
| 31–35 years | 0.88 | 0.63 to 1.23 |
| 36–40 years | 0.61 | 0.42 to 0.88** |
| 41–45 years | 1.19 | 0.77 to 1.84 |
| 46–50 years | 1.33 | 0.78 to 2.27 |
| 51 years and over | 0.96 | 0.51 to 1.80 |
| Marital status | ||
| Single (reference group) | 1.00 | |
| Married | 0.93 | 0.74 to 1.16 |
| Divorced | 1.31 | 0.49 to 3.52 |
| Widowed | 0.49 | 0.17 to 1.41 |
| Education level | ||
| Secondary school or lower (reference group) | 1.00 | |
| Bachelor degree | 1.38 | 1.05 to 1.82* |
| Higher education | 1.07 | 0.75 to 1.53 |
| Employment status | ||
| Retired (reference group) | 1.00 | |
| Unemployed | 0.56 | 0.41 to 0.76*** |
| Employed | 1.08 | 0.86 to 1.36 |
| University students | 1.34 | 1.05 to 1.69* |
| Monthly income level | ||
| Less than JD500 (reference group) | 1.00 | |
| JD500–JD1000 | 1.53 | 1.21 to 1.94*** |
| JD1001–JD1500 | 1.09 | 0.77 to 1.56 |
| JD1500 and above | 0.86 | 0.58 to 1.26 |
| Chronic diseases history | ||
| No (reference group) | 1.00 | |
| Yes | 1.17 | 0.84 to 1.64 |
p<0.05, **p<0.01, ***p<0.001.
Tablet-crushing practices
Table 5 shows the tablet-crushing practices of the study participants. Around 39.2% of the participants reported that they had split or crushed tablets to reach their desired dose, of which the vast majority (82.9%) were using scored tablets. Physicians were the most commonly reported source of advice regarding tablet splitting and crushing.
Table 5. Tablet-crushing practices of the study participants.
| Number | Variable | Frequency | Percentage |
| 1 | Have you ever split or crushed tablet to reach your desired dose? (n=1059) | ||
| Yes, I crushed the tablet to reach the desired dose | 282 | 26.6 | |
| Yes, I split the tablet to reach the desired dose | 127 | 12.0 | |
| Yes, I split and crushed tablet to reach the desired dose | 84 | 7.9 | |
| 2 | If yes, was this tablet scored or not? (n=493) | ||
| Scored | 408 | 82.9 | |
| 3 | Who advised you to split or crush the tablet of your medication? (n=493) | ||
| Physician | 149 | 30.2 | |
| No one | 108 | 21.9 | |
| Pharmacist | 142 | 28.8 | |
| Relative or friend | 73 | 14.9 | |
| Nurse | 21 | 4.2 | |
Discussion
Using medications reasonably and efficiently requires ensuring that patients receive the appropriate treatments customised to their clinical requirements, in the right dosage, and for the necessary time, all while reducing expenses for both patients and their communities. In the field of pharmaceutical treatment, the act of splitting or crushing medications has long been recognised as a common method for obtaining the prescribed dosage when a specific dose is not readily available. However, it is important to note that certain pharmaceutical dosage forms should never be crushed, as established by previous research.28,30 Therefore, this study aimed to evaluate the knowledge, attitudes and practices regarding medication splitting and crushing among the general public in Jordan.
Around 22.2% of the participants acknowledged the usefulness of tablet splitting/crushing in mitigating medication expenses, while 33.5% advocated for physicians to frequently recommend tablet splitting/crushing as a cost-saving measure. However, a separate study conducted in Canada indicated that tablet splitting/crushing appears to have limited effectiveness in reducing costs.28 It is crucial to exercise caution when considering tablet splitting/crushing due to potential issues such as inconsistent dosages and an elevated risk of errors in comprehending and administering the medication.
A significant proportion of the participants (84.1%) acknowledged the challenges associated with breaking tablets, which can be attributed to their size or hardness. The study further identified that tablet splitting/crushing is influenced by various factors including tablet size, shape, hardness, the method employed for splitting/crushing and human ability. Specifically, it was observed that smaller, rounder and harder tablets posed greater difficulty in breaking, resulting in tablet fragmentation and potential loss of medication.31 32 The study’s findings indicate that a majority of participants (67.0%) expressed uncertainty regarding the appropriateness of splitting or crushing tablets. Consequently, it is imperative to improve the availability of information regarding which dosage forms can be divided or crushed in order to reduce the likelihood of medication errors.33
Furthermore, a significant proportion of the study participants (75.8%) indicated their inclination to review package leaflet information in order to determine the appropriateness of splitting or crushing tablets. It is worth noting that tablet products approved by the US Food and Drug Administration (FDA) for splitting are required to include specific instructions in the patient package insert.34 Similarly, a comparable percentage (76.8%) of participants reported that they had never sought guidance from healthcare professionals regarding tablet splitting/crushing. Conversely, a study conducted in Malaysia revealed that approximately half of their participants would seek advice from healthcare professionals when uncertain about the feasibility of tablet splitting.35 A significant proportion of our study participants (90.0%) indicated that the modification of dosage forms falls under the purview of a doctor’s role or responsibility. This is supported by the fact that clinicians often find it necessary to modify oral dosage forms for patients due to various factors such as age-related changes in drug response and the unavailability of appropriate licensed dosage options. Furthermore, the adjustment of dosage forms to accommodate patient characteristics is considered a responsibility of healthcare professionals.
In this study, the majority of participants (84.8%) responded correctly that tablets with score lines can be divided, while tablets without score lines cannot be divided. The presence of score lines on tablets allows for dose flexibility, ease of swallowing and cost savings. This finding is supported by previous research indicating that splitting scored tablets is both approved by the FDA and considered safe and effective. However, it is concerning that only 11.2% of participants were able to correctly identify tablets that should not be split or crushed, and only 24.0% could accurately identify the division of scored tablets into equal parts. These results highlight the lack of accurate information on tablet splitting in drug information sources and emphasise the need for improved information to prevent medication errors. Similar studies have also shown that many patients are unaware of which medications can be split or crushed. The findings of the study indicate that a significant proportion of the study participants, namely 72.0%, demonstrated accurate knowledge regarding the limitations associated with splitting, crushing or dissolving tablets and capsules. It is important to note that not all oral drugs can be safely subjected to these actions, as doing so can have detrimental effects. This highlights the potential harm that can arise from the incorrect splitting of medications.36
The majority of the participants (67.1%) demonstrated accurate knowledge regarding the potential exacerbation of side effects when crushing an enteric-coated NSAID tablet. It is indeed true that enteric-coated medications are specifically designed to remain intact during their passage through the stomach, thereby releasing the active drug only on reaching the intestines. This formulation is frequently used for drugs that have the potential to cause stomach irritation, are prone to breakdown by gastric acids or require a delayed onset of action. Manipulating the enteric coating of these drugs has the potential to compromise the stability of the drug, its desired therapeutic benefits, or increase the probability of adverse reactions. In addition, it has been shown that these objects possess a high resistance to deformation, making them more challenging to crush.37,39 Moreover, it was observed that around 61.0% of the participants demonstrated an accurate understanding that the therapeutic effectiveness of a sustained-release tablet is diminished when it is crushed. This finding aligns with previous research indicating that dividing extended-release formulations can lead to an overdose due to unregulated release of the active ingredient.40
This research revealed that, on average, participants attained a mean knowledge score of 2.7 out of a maximum of 6 points. The obtained score represents 45% of the highest achievable score, suggesting a limited level of understanding in relation to tablet splitting and crushing. The limited knowledge observed in this context may be attributed to the absence of comprehensive tablet splitting and crushing information in drug references. This highlights the significance of improving such information in order to mitigate medication errors. It is crucial to enhance the availability of information pertaining to the safe division or crushing of medication dosage forms, as this will decrease the probability of medication errors and promote awareness regarding tablet crushing and splitting. This recommendation is supported by a study that investigated the knowledge, attitude and practices of community pharmacists.33 41 The findings indicate that although certain pharmacists demonstrate positive attitudes and possess adequate knowledge of the practice of tablet splitting and crushing, there remains potential for improvement. It is worth noting that there exists a necessity for enhancement in the guidance provided regarding the avoidance of dividing or crushing enteric-coated or sustained-release tablets.42
Around 39.2% of our study participants indicated that they engaged in tablet splitting or crushing in order to attain their desired dosage. Among this group, a significant majority (82.9%) reported doing so specifically with score tablets. It was observed that the prevailing perception of tablet splitting is primarily associated with the necessity for dose modification and the difficulty of swallowing tablets.43 Despite the ongoing importance of score tablets in facilitating patients' achievement of their desired dosage,44 it is worth noting that these tablets occasionally exhibit suboptimal performance along their scored lines.45
In our study, the findings from the binary logistic regression analysis indicated a significant association between individuals with bachelor’s degrees and those with an income level between JD500 and 1000 per month and their knowledge about tablet crushing. This suggests that education and income are influential factors in determining the level of knowledge individuals possess about tablet crushing. Moreover, the study also found that higher levels of education were linked to a greater understanding of medication, supporting the idea that education plays a role in enhancing medication knowledge.21 Additionally, the study highlights the impact of economic status on patients’ knowledge and utilisation of drugs.46 Furthermore, the findings of the study indicate that physicians were frequently cited as the primary source of guidance on tablet splitting and crushing. It was observed that community pharmacists often defer to the recommendations of physicians in this regard.42 However, it is crucial for physicians to acknowledge the challenges faced by patients in splitting tablets and to explore alternative dosage forms or strengths.47 Additionally, it is imperative for all healthcare professionals, including pharmacists, to actively participate and demonstrate attentiveness in assisting patients with tablet splitting and crushing. They should also actively engage in programmes aimed at addressing these issues for the wider population.48
In order to practice safe medicine usage, patients should take caution when dividing tablets, obtain accurate information from reputable sources, possess knowledge regarding which medications are suitable for splitting and which are not, particularly exercising care with coated and sustained-release tablets, and actively seek help from healthcare professionals. Furthermore, healthcare professionals have a pivotal role in providing guidance to patients and should take into account alternate dosage regimens as needed in order to promote the safe and economically efficient utilisation of medications. We recommend further patient education about the practice of tablet splitting to improve the public’s knowledge through dissemination by health practitioners and public health networks. This can be achieved with the help of informational materials distributed via hospitals, clinics, pharmacies and social media. Information dissemination can be improved significantly through collaboration with patient advocacy groups, healthcare organisations and governmental health agencies in disseminating clear, evidence-based guidelines concerning safe and effective practices when tablet splitting. That may extend to include education on tablet/splitting during regular clinical encounters aimed at providing patients with personalised counselling based on their individual treatment needs. The pharmacist should engage in active teaching at the time of dispensing medication regarding which medications can and cannot be crushed and provide written educational materials in a format that is easy to understand. Pharmacists are uniquely positioned to provide individual counselling and ensure that the patient is aware of potential risks. In collaboration with physicians and nurses, they can ensure consistent communication, offering alternative dosage forms, when possible, to ultimately promote safe medication practices in order to enhance patient safety and treatment efficacy. Healthcare professionals should be informed about the importance of enhancing public knowledge of tablet-splitting practices through medical conferences, journals and continuing medical education programmes. Supplementary strategies, such as incorporating pill-splitting guidelines into clinical protocols and employing decision support systems, are recommended to foster behavioural change in healthcare environments.
This study has limitations. The cross-sectional study design restricted the ability to examine causality among the study variables. The use of an online survey study is another limitation that might have affected the generalisation of our study findings as most of the study participants were young, female and had a college degree. There is justification for the dominance of younger, more educated, female participants in our study. Younger age categories are the main demographic group in Jordan and would thus engage more with online platforms leading to oversampling. In Jordan, 91.2% of the population is aged below 54 years and 52.8% aged below 25 years.49 Moreover, there is usually a greater tendency for females to respond to health-related surveys, as they are more concerned about health and show more care for their own health.50 Finally, online questionnaires are also more likely to be completed by people with a college degree because of their greater level of digital literacy and access to internet-based resources.23 Furthermore, self-administered questionnaires are vulnerable to recall and response bias.
Conclusion
This study emphasises the significance of improving tablet splitting and crushing knowledge and promoting prescription behaviours that prioritise safety and informed decision-making. The sensible and effective utilisation of pharmaceuticals is imperative for the overall welfare of patients and the mitigation of expenses. Tablet splitting can yield cost-saving benefits; however, it requires careful consideration due to the potential risks associated with irregular dosages and errors. It is advisable for patients to actively seek trustworthy sources of information, understand which tablets can be safely split and actively communicate with healthcare professionals in order to obtain appropriate advice. The correlation between levels of education and income and an individual’s understanding of medication underlines the importance of ensuring information is accessible. Furthermore, healthcare experts have a crucial role in providing guidance and advice to patients.
supplementary material
Acknowledgements
This study was supported by Isra University (Amman, Jordan).
Footnotes
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-087109).
Provenance and peer review: Not commissioned; externally peer reviewed.
Patient consent for publication: Not applicable.
Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Ethics approval: This study was approved by the Research Ethics Committee at the Faculty of Pharmacy at Isra University, Amman, Jordan (SREC/22/12/64). As participation in the study was voluntary, the research ethics committee approved the consent waiver. This study was conducted in accordance with the World Medical Association (WMA) Declaration of Helsinki.
Contributor Information
Abdolelah Jaradat, Email: abdolelah.jaradat@iu.edu.jo.
Esra'a Ali Alomari, Email: esraa.alomari@iu.edu.jo.
Mohammad Fouad Bayan, Email: mbayan@philadelphia.edu.jo.
Abdallah Y Naser, Email: abdallah.naser@iu.edu.jo.
Data availability statement
Data are available on reasonable request.
References
- 1.Thong MY, Manrique YJ, Steadman KJ. Drug loss while crushing tablets: Comparison of 24 tablet crushing devices. PLoS One. 2018;13:e0193683. doi: 10.1371/journal.pone.0193683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Saran AK, Holden NA, Garrison SR. Concerns regarding tablet splitting: a systematic review. BJGP Open. 2022;6:BJGPO.2022.0001. doi: 10.3399/BJGPO.2022.0001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saran AK, Holden NA, Garrison SR. To Split or Not to Split? Systematically Reviewing the Evidence Surrounding Pill-Splitting. BJGP Open. 2022 doi: 10.3399/BJGPO.2022.0001. [DOI] [Google Scholar]
- 4.Verrue C, Mehuys E, Boussery K, et al. Tablet-splitting: a common yet not so innocent practice. J Adv Nurs. 2011;67:26–32. doi: 10.1111/j.1365-2648.2010.05477.x. [DOI] [PubMed] [Google Scholar]
- 5.Woerdenbag HJ, Visser JC, Leferink Op Reinink MPAM, et al. Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets. Pharmaceutics. 2022;14:320. doi: 10.3390/pharmaceutics14020320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Quinzler R, Gasse C, Schneider A, et al. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62:1065–73. doi: 10.1007/s00228-006-0202-3. [DOI] [PubMed] [Google Scholar]
- 7.Zaid AN, Al-Ramahi R, Shahed Q, et al. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine. Int J Pharm Pract. 2012;20:9–14. doi: 10.1111/j.2042-7174.2011.00157.x. [DOI] [PubMed] [Google Scholar]
- 8.Brustugun J, Birkedal Aas E, Tho I, et al. Comparing Two Methods of Tablet Manipulation to Adjust the Warfarin Dose in Paediatric Care. Pharmaceutics. 2020;12:375. doi: 10.3390/pharmaceutics12040375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Taylor S, Glass BD. Altering dosage forms for older adults. Aust Prescr. 2018;41:191–3. doi: 10.18773/austprescr.2018.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundamemntal Clinical Pharma . 2003;17:281–99. doi: 10.1046/j.1472-8206.2003.00140.x. [DOI] [PubMed] [Google Scholar]
- 11.Strassburg CP, Strassburg A, Kneip S, et al. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut. 2002;50:259–65. doi: 10.1136/gut.50.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Seybold ME, Drachman DB. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med. 1974;290:81–4. doi: 10.1056/NEJM197401102900204. [DOI] [PubMed] [Google Scholar]
- 13.Tahaineh LM, Gharaibeh SF. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice. J Pharm Pract. 2012;25:471–6. doi: 10.1177/0897190012442716. [DOI] [PubMed] [Google Scholar]
- 14.Lenzini PA, Grice GR, Milligan PE, et al. Optimal initial dose adjustment of warfarin in orthopedic patients. Ann Pharmacother. 2007;41:1798–804. doi: 10.1345/aph.1K197. [DOI] [PubMed] [Google Scholar]
- 15.Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. Am J Med. 2000;109:481–8. doi: 10.1016/s0002-9343(00)00545-3. [DOI] [PubMed] [Google Scholar]
- 16.Bachynsky J, Wiens C, Melnychuk K. The Practice of Splitting Tablets. Pharmacoeconomics. 2002;20:339–46. doi: 10.2165/00019053-200220050-00005. [DOI] [PubMed] [Google Scholar]
- 17.Green G, Berg C, Polli J, editors. Pharmacopeial Standards for the Subdivision Characteristics of Scored Tablets. Pharmacop Forum; 2009. [Google Scholar]
- 18.Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm. 1999;56:2542–5. doi: 10.1093/ajhp/56.24.2542. [DOI] [PubMed] [Google Scholar]
- 19.Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. Ann Pharmacother. 2002;36:205–9. doi: 10.1345/aph.1A233. [DOI] [PubMed] [Google Scholar]
- 20.Cohen JS. Ways to minimize adverse drug reactions. Postgrad Med. 1999;106:163–72. doi: 10.3810/pgm.1999.09.688. [DOI] [PubMed] [Google Scholar]
- 21.van Santen E, Barends DM, Frijlink HW. Breaking of scored tablets: a review. Eur J Pharm Biopharm. 2002;53:139–45. doi: 10.1016/s0939-6411(01)00228-4. [DOI] [PubMed] [Google Scholar]
- 22.Shailesh K, Vaishali L. Review on: Alternatives to large dosage forms for ease of swallowing. J Drug Deliv Sci Technol. 2020;57:101712. doi: 10.1016/j.jddst.2020.101712. [DOI] [Google Scholar]
- 23.Gill D, Spain M, Edlund BJ. Crushing or splitting medications: unrecognized hazards. J Gerontol Nurs. 2012;38:8–12. doi: 10.3928/00989134-20111213-01. [DOI] [PubMed] [Google Scholar]
- 24.Heron RJL. Health effects of exposure to active pharmaceutical ingredients (APIs) Occup Med. 2003;53:357–62. doi: 10.1093/occmed/kqg115. [DOI] [PubMed] [Google Scholar]
- 25.Lombardo J, Roussel C. Highlighting the risk of occupational exposure to hazardous drugs in the health care setting. Pharm Times. 2018;15 [Google Scholar]
- 26.Root T, Tomlin S, Erskine D. Royal Pharmaceutical Society; 2011. Pharmaceutical issues when crushing, opening or splitting oral dosage forms. [Google Scholar]
- 27.Horn JR, Howden CW. Review article: similarities and differences among delayed‐release proton‐pump inhibitor formulations. Aliment Pharmacol Ther . 2005;22:20–4. doi: 10.1111/j.1365-2036.2005.02714.x. [DOI] [PubMed] [Google Scholar]
- 28.Norman A, Hawkey CJ. What you need to know when you prescribe a proton pump inhibitor. Frontline Gastroenterol. 2011;2:199–205. doi: 10.1136/flgastro-2011-100006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mitchell JF. Oral Dosage Forms That Should Not Be Crushed. Institute for Safe Medication Practices; 2014. [Google Scholar]
- 30.Raebel MA, Carroll NM, Andrade SE, et al. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006;12:268–74. [PubMed] [Google Scholar]
- 31.McCudden CR. Quality, origins and limitations of common therapeutic drug reference intervals. Diagnosis (Berl) 2018;5:47–61. doi: 10.1515/dx-2018-0001. [DOI] [PubMed] [Google Scholar]
- 32.Jedinger N, Khinast J, Roblegg E. The design of controlled-release formulations resistant to alcohol-induced dose dumping--a review. Eur J Pharm Biopharm. 2014;87:217–26. doi: 10.1016/j.ejpb.2014.02.008. [DOI] [PubMed] [Google Scholar]
- 33.Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations. Clin Drug Investig. 2017;37:1117–24. doi: 10.1007/s40261-017-0561-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Alyami HS, Ali DK, Jarrar Q, et al. Taste Masking of Promethazine Hydrochloride Using l-Arginine Polyamide-Based Nanocapsules. Molecules. 2023;28:748. doi: 10.3390/molecules28020748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ntemi P, Walker R, Khamanga S. Design, evaluation and optimization of taste masked clarithromycin powder. Pharmazie Int J Pharm Sci. 2019;74:721–7. doi: 10.1691/ph.2019.8116. [DOI] [PubMed] [Google Scholar]
- 36.Mahajan A. Formulation and evaluation of fast dissolving buccal films of sertraline. Int J Drug Dev Res. 2012;4:220–6. [Google Scholar]
- 37.Davies NM. Sustained release and enteric coated NSAIDs: are they really GI safe? J Pharm Pharm Sci. 1999;2:5–14. [PubMed] [Google Scholar]
- 38.Mennella JA, Spector AC, Reed DR, et al. The bad taste of medicines: overview of basic research on bitter taste. Clin Ther. 2013;35:1225–46. doi: 10.1016/j.clinthera.2013.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm. 2004;30:429–48. doi: 10.1081/ddc-120037477. [DOI] [PubMed] [Google Scholar]
- 40.Bowman C. Administration of drugs to patients with swallowing difficulties. 2007
- 41.Akram G, Mullen AB. Paediatric nurses’ knowledge and practice of mixing medication into foodstuff. Int J Pharm Pract. 2012;20:191–8. doi: 10.1111/j.2042-7174.2011.00179.x. [DOI] [PubMed] [Google Scholar]
- 42.Mercovich N, Kyle GJ, Naunton M. Safe to crush? A pilot study into solid dosage form modification in aged care. Australas J Ageing. 2014;33:180–4. doi: 10.1111/ajag.12037. [DOI] [PubMed] [Google Scholar]
- 43.Zaid A, Abdallah Y, Zyoud S. Knowledge, Attitudes, and Practices of Pharmacists Toward Splitting or Crush-ing Oral Solid Dosage Forms in Palestine: Safety and Therapeutic Implications. Palestinian Med Pharm J. 2019;4:2. doi: 10.59049/2790-0231.1010. [DOI] [Google Scholar]
- 44.Bachynsky J, Wiens C, Melnychuk K. The practice of splitting tablets: cost and therapeutic aspects. Pharmacoeconomics. 2002;20:339–46. doi: 10.2165/00019053-200220050-00005. [DOI] [PubMed] [Google Scholar]
- 45.Gee M, Hasson NK, Hahn T, et al. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm . 2002;8:453–8. doi: 10.18553/jmcp.2002.8.6.453. [DOI] [PubMed] [Google Scholar]
- 46.McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy. 1998;18:193–7. [PubMed] [Google Scholar]
- 47.Polli JE, Kim S, Martin BR. Weight uniformity of split tablets required by a Veterans Affairs policy. J Manag Care Pharm . 2003;9:401–7. doi: 10.18553/jmcp.2003.9.5.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Gracia-Vásquez SL, González-Barranco P, Camacho-Mora IA, et al. Medications that should not be crushed. Med Univ. 2017;19:50–63. doi: 10.1016/j.rmu.2017.03.001. [DOI] [Google Scholar]
- 49.Trivedi M, Patel H, Dave R. A Review on Tablet Scoring: Background, History and Current Regulatory Considerations. JPRI. 2018;20:1–7. doi: 10.9734/JPRI/2017/39027. [DOI] [Google Scholar]
- 50.Nouri AI, Aldraimly M, Lamfon NA, et al. Knowledge, Attitudes, and Practices of Pills Splitting in Malaysia: A Cross-Sectional Study. JYP. 2021;13:411–6. doi: 10.5530/jyp.2021.13.99. [DOI] [Google Scholar]
